Prosecution Insights
Last updated: August 06, 2026

Syndicated Law Pc

7 pending office actions • 6 clients • 7 examiners • 4 art units • 0 of 7 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Quality Metrics (n=388 apps, methodology: how we score firms)

91.0%
Allowance Rate
n=388
+1.01σ
Allowance Rate (norm)
n=388
2.8
OAs to Allowance
n=284
-0.48σ
OAs to Allow (norm)
n=284
873 days
Time to Allowance
n=284
+8.1pp
Interview Lift
n=388
21.5%
RCE Rate
n=388
0.4%
Appeal Rate
n=388

Rejection Performance (% of received rejections ultimately overcome)

78.0%
§101 Overcome
n=41
86.9%
§102 Overcome
n=84
90.6%
§103 Overcome
n=160
86.8%
§112 Overcome
n=174

Specialization & Scale

A61K, A61P, G06Q
Top CPC Subclasses
28%
Top-3 CPC Share
n=388
1
Practitioners
n=388
388.0
Apps / Practitioner
n=388

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (57%)
1
Medium (14%)
1
Easy (14%)
1
Unknown (14%)

Rejection Statute Mix

BucketCases
§101 + other2 (29%)
§112 only1 (14%)
Double-patenting + other1 (14%)
Multi-statute (no §101)2 (29%)
No statute on record1 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
71% of docket
1
Information Tech
14% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MERCADO VARGAS, ARIEL 1 71.6% +29.5%
COX, NATISHA D 1 72.9% +21.2%
BRANDSEN, BENJAMIN MICHAEL 1 61.0% +17.6%
CHO, DAVID H 1 37.5% +73.5%
TAKENAKA, RISA 1 28.6% +100.0%
HIBSHMAN, SARAH GRACE 1 39.6% +43.0%
PENNINGTON, KATIE LEIGH 1 27.6% +58.4%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18554442 A COMPOSITION FOR IMPROVING GUT MICROBIOTA, BEHAVIOURAL PATTERN, ALPHA-SYNUCLEIN LEVELS, SLEEP PATTERN AND/OR SERUM MELATONIN CHO, DAVID H 19d overdue
18561083 METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN BRANDSEN, BENJAMIN MICHAEL
18027892 CELL POPULATION PRODUCTION METHOD TAKENAKA, RISA
18001994 BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE HIBSHMAN, SARAH GRACE
17601861 CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY PENNINGTON, KATIE LEIGH

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18554442 A COMPOSITION FOR IMPROVING GUT MICROBIOTA, BEHAVIOURAL PATTERN, ALPHA-SYNUCLEIN LEVELS, SLEEP PATTERN AND/OR SERUM MELATONIN CHO, DAVID H 19d overdue
18766372 Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction COX, NATISHA D 70d
18780967 USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS MERCADO VARGAS, ARIEL
18561083 METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN BRANDSEN, BENJAMIN MICHAEL
18027892 CELL POPULATION PRODUCTION METHOD TAKENAKA, RISA
18001994 BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE HIBSHMAN, SARAH GRACE
17601861 CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY PENNINGTON, KATIE LEIGH

Client Portfolio (6 clients)

Top Art Units

Art UnitApps
16933
24581
16321
16341

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18780967 USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS Jammit, Inc. MERCADO VARGAS, ARIEL §112DP Non-Final OA Pending Jul 23, 2024
18766372 Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction Turion Corporation COX, NATISHA D 2458 §112 Non-Final OA 70d Pending Jul 08, 2024
18561083 METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN National University Corporation Kochi University BRANDSEN, BENJAMIN MICHAEL 1693 §101§102§112DP Non-Final OA Pending Nov 15, 2023
18554442 A COMPOSITION FOR IMPROVING GUT MICROBIOTA, BEHAVIOURAL PATTERN, ALPHA-SYNUCLEIN LEVELS, SLEEP PATTERN AND/OR SERUM MELATONIN Sophy Inc. CHO, DAVID H 1693 §101§102§103§112Other Non-Final OA 19d overdue Pending Oct 06, 2023
18027892 CELL POPULATION PRODUCTION METHOD Gn Incorporation Co. Ltd. TAKENAKA, RISA 1632 §102§103§112 Final Rejection Pending Mar 22, 2023
18001994 BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE Sophy Inc. HIBSHMAN, SARAH GRACE 1693 §102§103§112 Final Rejection Pending Dec 15, 2022
17601861 CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY Jbm Incorporation PENNINGTON, KATIE LEIGH 1634 Other Non-Final OA Pending Oct 06, 2021

Managing Syndicated Law Pc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month